Akanda (NASDAQ:AKAN) Raised to “Sell” at Wall Street Zen

Akanda (NASDAQ:AKAN) was upgraded by analysts at Wall Street Zen from a “strong sell” rating to a “sell” rating in a report issued on Saturday.

Separately, Weiss Ratings lowered shares of Akanda from a “sell (d-)” rating to a “sell (e+)” rating in a report on Monday, May 18th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Akanda Price Performance

NASDAQ AKAN opened at $7.73 on Friday. The company’s 50-day simple moving average is $14.93 and its two-hundred day simple moving average is $10.53. Akanda has a one year low of $2.30 and a one year high of $209.02.

Akanda (NASDAQ:AKAN) last posted its quarterly earnings results on Tuesday, June 9th. The company reported ($317.90) EPS for the quarter.

Akanda Company Profile

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.